Design, Synthesis, and Biological Evaluation of New 8-Heterocyclic Xanthine Derivatives as Highly Potent and Selective Human A2B Adenosine Receptor Antagonists

Journal of Medicinal Chemistry

Volumn 47, Issue 6, 2004, Pages 1434-1447

  Baraldi, Pier Giovanni ^a   Tabrizi, Mojgan Aghazadeh ^a   Preti, Delia ^a   Bovero, Andrea ^a   Romagnoli, Romeo ^a   Fruttarolo, Francesca ^a   Zaid, Naser Abdel ^a   Moorman, Allan R ^b   Varani, Katia ^a   Gessi, Stefania ^a   Merighi, Stefania ^a   Borea, Pier Andrea ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b King Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3,4 DIMETHOXYPHENYL) N [5 (2,6 DIOXO 1,3 DIPROPYL 2,3,6,7 TETRAHYDRO 1H PURIN 8 YL) 1 METHYL 1H PYRAZOL 3 YL]ACETAMIDE; 8 PYRAZOLO 1,3 DIPROPYL 1H PURINE 2,6 DIONE DERIVATIVE; ACETAMIDE; ACETANILIDE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; AMIDE; CYCLIC AMP; HETEROCYCLIC COMPOUND; ISOXAZOLE; N (3,4 DIMETHOXYPHENYL) 2 [5 (2,6 DIOXO 1,3 DIPROPYL 2,3,6,7 TETRAHYDRO 1H PURIN 8 YL) 1 METHYL 1H PYRAZOL 3 YLOXYL]ACETAMIDE; N BENZO[1,3]DIOXOL 5 YL 2 [5 (2,6 DIOXO 1,3 DIPROPYL 2,3,6,7 TETRAHYDRO 1H PURIN 8 YL) 1 METHYL 1H PYRAZOL 3 YLOXY]ACETAMIDE; OXYACETAMIDE; PYRAZOLE; PYRIDAZINE; PYRIDINE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; UREA; XANTHINE DERIVATIVE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DESIGN; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; NONHUMAN; RADIOASSAY; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; DRUG DESIGN; HUMANS; ISOXAZOLES; PYRIDAZINES; PYRIDINES; RADIOLIGAND ASSAY; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION; XANTHINES;

EID: 12144290205     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0309654     Document Type: Article

References (46)

1. 2B receptors. Pharmacol. Rev. 1997, 49, 381-402.
2. 2B receptors: A novel target in asthma. Trends Pharmacol. Sci. 1998, 19, 148-153.
3. Ralevic, V.; Burnstock, G. Receptors for purines and pyrimidines. Pharmacol. Rev. 1998, 50, 413-492.
4. 2B adenosine receptor mediates cAMP responses to adenosine receptor agonists in human intestinal epithelia. J. Biol. Chem. 1995, 270, 2387-2394.
5. 2B receptors evoke interleukine-S secretion in human mast cells: An enprophylline-sensitive mechanism with implication for asthma. J. Clin. Invest. 1995, 96, 1979-1986.
6. Boyle, D.; Sajjadi, F. G. Inhibition of synoviosyte collagenase gene expression by adenosine receptor stimulation. Arthritis Rheum. 1996, 39, 923-930.
7. 2B receptors. Hypertension 1998, 31, 516-521.
8. 2B receptors coupled to distinct interactive signaling pathways in intestinal muscle cells. J. Pharmacol. Exp. Ther. 1995, 274, 243-246.
9. 2+ influx and activates a protein phosphatase in bovine adrenal chromaffin cells. J. Neurochem. 1995, 64, 77-84.
10. Haynes, J. J.; Obikao, B.; Thompson, W. J.; Downey, J.; Adenosine induced vasodilation receptor characterization in pulmonary circulation. Am. J. Physiol. 1995, 268, H1862-H1868.
11. Fozard, J. R.; Hannon, J. P. Adenosine receptor ligands: Potential as therapeutic agents in asthma and COPD. Pulm. Pharmacol. Ther. 1999, 12, 111-114.
12. Marx, D.; Ezeamuzie, C. I.; Nieber, K.; Szenlenyi, I. Therapy of bronchial asthma with adenosine receptor agonists or antagonists. Drug News Perspect. 2001, 14, 89-100.
13. 2B receptors as therapeutic targets. Drug Dev. Res. 1998, 45, 198-206.
14. 2B receptors. Biochem. Pharmacol. 1998, 55, 627-633.
15. Fredholm, B. B.; Irenius, E.; Kull, B.; Schulte, G. Comparison of the potency of adenosine as an agonist at human adenosine receptor expressed in chinese hamster ovary cells. Biochem. Pharmacol. 2001, 61, 443-448.
16. Müller, C. E.; Stein, B. Adenosine receptor antagonists: Structures and potential therapeutic applications. Curr. Pharm. Des. 1996, 2, 501-530.
17. 2B adenosine receptors. Drug. Des. Discov. 1999, 16, 217-226.
18. 2B adenosine receptor. Drug Dev. Res. 1999, 47, 178-188.
19. 2B adenosine receptors. Drug Dev. Res. 1999, 47, 45-53.
20. 2B adenosine receptor. J. Med. Chem. 2000, 43, 1165-1172.
21. 2B adenosine receptors. Biochem. Pharmacol. 2001, 61, 657-663.
22. 3 receptor subtypes. J. Med. Chem. 1998, 41, 2835-2845.
23. 2B receptors. Bioorg. Med. Chem. 2003, 11, 77-85.
24. 2A adenosine antagonists. J. Med. Chem. 1996, 39, 1164-1171.
25. 2A adenosine receptor antagonists. J. Med. Chem. 1998, 41, 2126-2133.
26. 3 adenosine receptor antagonists. J. Med. Chem. 1999, 42, 4473-4478.
27. 3 adenosine receptor ligands; history and perspectives. Med. Res. Rev. 2000, 20, 103-128.
28. 2B adenosine receptor. Drug Dev. Res. 2001, 53, 225-235.
29. 2B-selective adenosine receptor antagonists. J. Med. Chem. 2001, 45, 1500-1510.
30. 2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions. J. Med. Chem. 2002, 45, 2131-2138.
31. 1 adenosine receptors. J. Med. Chem. 1992, 35(5), 924-30.
32. 2B adenosine receptors. Curr. Top. Med. Chem. 2003, 3, 427-443.
33. 3 adenosine receptors. Mol. Pharmacol. 2000, 57, 968-975.
34. Papesch, V.; Schroeder, E. F. Synthesis of 1-mono- and 1,3-substituted 6-amino-uracils. Diuretic activity. J. Org. Chem. 1951, 16, 1879-1890.
35. 2 Affinity J. Med. Chem. 1991, 34, 1431-1435
36. Lee, H. H.; Bruce, F.; Cain, W.; Denny, A. Synthesis and characterization of masked aminopyrazolecarboxylic acid synthons. J. Org. Chem. 1989, 54, 428-431.
37. Morishita, M.; Kobayashi, J.; Yamada, H.; Yajima, T. Synthesis of 3-chloropyridazine-6-carboxylic acid hydrazide and selective hydrazinolysis of 3,6-substituted pyridazines. Chem. Pharm. Bull. 1994, 42; 2, 371-372.
38. Shtacher, G.; Taub, W. Synthesis of chelating compounds to be used as potential bone seekers. J. Med. Chem. 1966, 9, 197-203.
39. Sucrow, W.; Mentzel, C.; Slopianka, M. Enehydrazines, 9. 1-Alkyl-3-hydroxypyrazole aus hydrazonen oder hydrazinen. Chem Ber. 1974, 107, 1318-1328.
40. Fehlauer, A.; Grosz, K. P.; Slopianka, M.; Sucrow, W.; Lockley, W. J. S. ; Lwowski, W. Enehydrazines, 11. Structure and reactions of dimethyl 2-(1-methylhydrazino)maleate. Chem Ber. 1976, 109, 253-260.
41. Hines, J. W.; Strammer, C. H. 3-Hydroxyisoxazole-5-hydroxamic acid. J. Med. Chem. 1977, 20, 965-967.
42. Goeth, H.; Gagneux, Andre R.; Eugster, Conrad H.; Schmid, H. Compounds of amanita fungi. XXV. Photoreactions of N-heterocycles. 6. 2(3H)-oxazolone through photo rearrangement of 3-hydroxyisoxazoles. Synthesis of muscazone. Helv. Chim. Acta 1967, 50, 137-142.
43. Klotz, K. N.; Hessling, J.; Hegler, J.; Owman, C.; Kull, B.; Fredholm, B. B.; Lohse, M. J. Comparative pharmacology of human adenosine receptor subtypes-characterization of stably transfected receptors in CHO cells. Naunyn-Schmied. Arch Pharm. 1998, 357, 1-9.
44. Bradford, M. M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding. Anal. Biochem. 1976, 72, 248-254.
45. 50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.
46. Munson, P. J.; Rodbard, D. Ligand: A versatile computerized approach for the characterization of ligand binding systems. Anal. Biochem. 1980, 107, 220-239.